Mango + Probiotic for Obesity

JA
OA
Overseen ByObed Akwaa Harrison, Doctor Philosophy
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: Prairie View A&M University

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how consuming mangoes rich in gallotannins (a type of antioxidant) and a probiotic called Lactiplantibacillus pentosus can help reduce inflammation in people with obesity. Researchers aim to determine if combining mango and probiotics is more effective than using each separately. Participants will be divided into groups to test different combinations of these substances, while a lean group will serve as a control. The trial seeks individuals classified as obese who may experience inflammation-related issues. As an unphased trial, this study offers a unique opportunity to contribute to understanding new dietary approaches to reduce inflammation.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you are on medications for type 2 diabetes or related diseases, you may not be eligible to participate.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Previous studies have shown that mangoes high in gallotannins offer promising health benefits. Regular consumption of these mangoes may reduce inflammation in overweight individuals, suggesting that the mango treatment is easy for the body to handle.

Lactiplantibacillus pentosus, a probiotic considered safe, has been used in foods for a long time. Research indicates that this probiotic can balance gut bacteria without causing major side effects in healthy individuals.

When combined, gallotannin-rich mangoes and Lactiplantibacillus pentosus have not raised major safety concerns in studies. They may work well together to improve gut health.

Overall, existing research suggests both treatments are well-tolerated. However, always consult a healthcare provider before joining a trial.12345

Why are researchers excited about this trial's treatments?

Researchers are excited about these treatments because they offer a unique approach to tackling obesity. Unlike traditional treatments that often focus on diet and exercise or medications targeting appetite regulation, the new approach uses a gallotannin-rich mango extract and a probiotic called Lactiplantibacillus pentosus. Gallotannins are known for their antioxidant properties, which might help in managing body weight, while L. pentosus could aid in gut health, potentially influencing weight loss. This combination targets both the metabolic and gut microbiota aspects of obesity, making it a promising alternative to existing options.

What evidence suggests that this trial's treatments could be effective for obesity?

This trial will evaluate the effects of gallotannin-rich mango and Lactiplantibacillus pentosus on obesity. Studies have shown that mangoes rich in gallotannins can help reduce obesity by affecting fat cells and promoting fat burning. For example, one study found that mango extracts decreased fat storage and increased the body's heat production, which burns calories. Another study showed that regularly eating mangoes exposes individuals to beneficial compounds that can aid in weight management.

Additionally, research on Lactiplantibacillus pentosus, a type of probiotic, suggests it can help manage obesity by improving gut health and influencing metabolism. Some studies found that this probiotic reduced weight gain and improved metabolic health in animals. In this trial, participants will be assigned to different arms to receive either gallotannin-rich mango, Lactiplantibacillus pentosus, a combination of both, or no additional treatment. This suggests that both mangoes and Lactiplantibacillus pentosus may help reduce obesity and related inflammation.26789

Who Is on the Research Team?

JA

Janet Antwi, Doctor of Philosophy

Principal Investigator

Prairie View A&M University

Are You a Good Fit for This Trial?

This trial is for men and women aged 18-55 who are either lean (BMI 18-24.9) or obese (BMI 30-40). People can't join if they have serious health issues like heart disease, cancer, liver/kidney problems, recent antibiotic use, certain medications, pregnancy, allergies to mango/gallotannins, or substance abuse.

Inclusion Criteria

Participants will be measured for anthropometric parameters such as height and weight to confirm their BMI before being registered for the study
BMI ranges: 18-24.9 kg/m2 (lean) and 30-40 kg/m2 (obese)
I am between 18 and 55 years old and am either lean or obese.

Exclusion Criteria

Participation in other interventional research study
I have had a heart attack, stroke, or cancer in the past.
Recurrent hospitalizations
See 11 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants are grouped into 4 treatment groups and receive interventions with GT extract, L. pentosus, or both

1 week
1 visit (in-person)

Follow-up

Participants are monitored for changes in inflammatory biomarkers and gut microbiome composition

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Gallotannin-rich mango
  • Lactiplantibacillus pentosus
  • No Treatment Added

Trial Overview

The study tests how gallotannin-rich mango juice and a probiotic supplement (Lactiplantibacillus pentosus), alone or together, affect gut bacteria and inflammation in obese people compared to lean controls. Participants are divided into four groups based on the intervention received.

How Is the Trial Designed?

4

Treatment groups

Active Control

Placebo Group

Group I: GT extract + Lactiplantibacillus pentosus armActive Control2 Interventions
Group II: Gallotannin extract from mango onlyActive Control1 Intervention
Group III: Lactiplantibacillus pentosus supplement armActive Control1 Intervention
Group IV: Control groupPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Prairie View A&M University

Lead Sponsor

Trials
1
Recruited
30+

Citations

Assessing Anti-Adipogenic Effects of Mango Leaf Tea and ...

This study investigated the effect of MGF, and tea brewed with mango leaves in cultured adipocytes. The anti-adipogenic efficacy of mango leaf tea (MLT) and ...

African Mango (Irvingia gabonensis) Extract for Weight Loss

Irvingia gabonensis demonstrates potential for significant weight loss of up to 12 kilograms in overweight and obese subjects over a period of 10 weeks with ...

Gallotannin derivatives from mango ( Mangifera indica L. ...

The results suggest that the intake of mango extract-enriched foods in association with a correct lifestyle could exert beneficial effects to counteract obesity ...

Emerging Research Suggests Mango Consumption Holds ...

Emerging Research Suggests Mango Consumption Holds Potential to Positively Impact Blood Sugar in Obese Individuals and Mango Polyphenols May ...

Gallotannin derivatives from mango (Mangifera indica L. ...

This study demonstrates that gallotannin derivatives suppress lipid accumulation and promote thermogenesis in adipocytes, at least in part, through the ...

Effects of Gallotannins on the Gut Microbiome and How it ...

The goal of this clinical trial is to understand how gallotannin-rich (GT-rich) mangoes can reduce the inflammatory markers in obese individuals in vitro.

Daily mango (Mangifera indica L.) consumption supplemented ...

Mango, rich in gallotannins with antioxidant and anti-inflammatory properties, may enhance cognitive performance in overweight/obese individuals ...

Recognition of Gallotannins and the Physiological Activities

Gallotannins, characterized with the glycosidic core and galloyl unit, are seemed as vital components of hydrolyzable tannins.

Effects of fresh mango consumption on cardiometabolic ...

Mango consumption reduced fasting glucose but did not affect insulin or HbA1c. Mango consumption increased antioxidant capacity and reduced inflammation.